Page last updated: 2024-08-22

chromium and Pancreatic Neoplasms

chromium has been researched along with Pancreatic Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clements, D; Giacomantonio, CA; Gujar, SA; Hill, R; Lee, PW; Madureira, PA; Rabb, M; Waisman, DM1
Bressan, V; Girardi, P; Mabilia, T; Merler, E1
Charnley, RM; Cresswell, J; French, JJ; Kirby, JA; Seymour, K; Wong, WK1
ALESSANDRI, H; GUZMAN, C; KATZ, R; VELASCO, M1
Johnson, E; Kroprowski, C; Lang, P; Lustig, R; Order, SE; Principato, R; Siegel, JA; Wallner, PE; Zeiger, LS1
Eisold, S; Gebert, J; Haack, K; Linnebacher, M; von Knebel Doeberitz, M; Zöller, M1
Anghileri, LJ; Dogàn, EB1

Trials

1 trial(s) available for chromium and Pancreatic Neoplasms

ArticleYear
Preliminary experience of infusional brachytherapy using colloidal 32P.
    Annals of the Academy of Medicine, Singapore, 1996, Volume: 25, Issue:3

    Topics: Astrocytoma; Brachytherapy; Brain Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Small Cell; Chemoembolization, Therapeutic; Chromium; Colloids; Dexamethasone; Head and Neck Neoplasms; Hodgkin Disease; Humans; Injections, Intralesional; Liver Neoplasms; Lung Neoplasms; Pancreatic Neoplasms; Phosphorus Radioisotopes; Radiography, Interventional; Radioimmunotherapy; Radiotherapy Dosage; Remission Induction; Serum Albumin; Tomography, X-Ray Computed

1996

Other Studies

6 other study(ies) available for chromium and Pancreatic Neoplasms

ArticleYear
Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy.
    Cell death & disease, 2013, Sep-05, Volume: 4

    Topics: 14-3-3 Proteins; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Line, Tumor; Chromium; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; DNA Damage; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Models, Biological; Pancreatic Neoplasms; Protein Biosynthesis; Proto-Oncogene Proteins; Remission Induction; Transcription, Genetic; Tumor Suppressor Protein p53

2013
[Confirmation of an excess of cancer mortality in a cohort of workers of a chromium thin-layer plating].
    Epidemiologia e prevenzione, 2015, Volume: 39, Issue:3

    Topics: Carcinogens; Chromium; Cohort Studies; Electroplating; Follow-Up Studies; Humans; Italy; Lung Neoplasms; Metallurgy; Nose Neoplasms; Occupational Diseases; Occupational Exposure; Pancreatic Neoplasms; Retrospective Studies; Risk Factors; Time Factors; Tin

2015
T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?
    British journal of cancer, 2002, Oct-21, Volume: 87, Issue:9

    Topics: Antigens, CD; Cadherins; Cell Adhesion; Cell Division; Cell Movement; Chromium; Flow Cytometry; Humans; Immunophenotyping; Immunotherapy; Integrin alpha Chains; Integrins; Pancreatic Neoplasms; Receptors, Antigen, T-Cell; T-Lymphocytes; Transfection; Tumor Cells, Cultured

2002
RED CELL SURVIVAL ESTIMATED BY RADIOACTIVE CHROMIUM IN HEPATOBILIARY DISEASE.
    Gastroenterology, 1964, Volume: 46

    Topics: Alcoholism; Bilirubin; Blood Chemical Analysis; Cell Survival; Chlorpromazine; Chromium; Chromium Isotopes; Erythrocytes; Gallstones; Hemoglobins; Hemolysis; Hepatitis; Hepatitis A; Hepatitis B virus; Iproniazid; Jaundice; Jaundice, Obstructive; Liver; Liver Cirrhosis; Pancreatic Neoplasms; Prednisolone

1964
Induction of protective immunity against syngeneic rat cancer cells by expression of the cytosine deaminase suicide gene.
    Cancer gene therapy, 2000, Volume: 7, Issue:10

    Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; CD4 Antigens; CD8 Antigens; Chromium; Cytosine Deaminase; Female; Flow Cytometry; Gene Expression; Genetic Therapy; Genetic Vectors; Horseradish Peroxidase; Immunity, Cellular; Immunization; Immunoenzyme Techniques; Injections, Intraperitoneal; Injections, Subcutaneous; Neoplasm Transplantation; Nucleoside Deaminases; Pancreatic Neoplasms; Rats; Sensitivity and Specificity; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured

2000
Prevention of abdominal metastases after intraperitoneal injection of Yoshida ascites cells: use of a new colloidal 32P-chromic phosphate.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1968, Volume: 9, Issue:11

    Topics: Abdominal Neoplasms; Acids; Adnexal Diseases; Animals; Chromium; Colloids; Female; Injections, Intraperitoneal; Intestinal Neoplasms; Male; Neoplasm Metastasis; Neoplasm Transplantation; Pancreatic Neoplasms; Peritoneal Neoplasms; Phosphates; Phosphorus Isotopes; Rats; Sarcoma, Yoshida

1968